Unconfigured Ad

Collapse

Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by laura, 05-09-2011, 04:42 AM
35 responses
108,217 views
0 reactions
Last Post laura
by laura
 
Started by sci_guy, 01-23-2008, 11:19 PM
236 responses
689,250 views
1 reaction
Last Post ECO
by ECO
 
Started by Hel, 12-04-2013, 08:32 AM
1 response
1,486 views
0 reactions
Last Post GenoMax
by GenoMax
 
Started by shengzizhang, 02-07-2013, 09:06 AM
2 responses
2,835 views
0 reactions
Last Post moredd
by moredd
 
Started by cmccabe, 12-03-2013, 02:38 PM
3 responses
2,309 views
0 reactions
Last Post dpryan
by dpryan
 
Started by arkilis, 12-01-2013, 10:55 PM
8 responses
8,040 views
0 reactions
Last Post arkilis
by arkilis
 
Started by vl80, 12-03-2013, 04:29 PM
2 responses
2,355 views
0 reactions
Last Post GenoMax
by GenoMax
 
Started by Mokinhas, 09-12-2013, 07:14 AM
1 response
3,147 views
0 reactions
Last Post moredd
by moredd
 
Started by lucer105, 12-02-2013, 09:46 PM
3 responses
2,767 views
0 reactions
Last Post GenoMax
by GenoMax
 
Started by spacup, 11-26-2013, 08:32 AM
3 responses
2,442 views
0 reactions
Last Post spacup
by spacup
 
Started by primordialsoup77, 12-03-2013, 07:31 PM
0 responses
1,832 views
0 reactions
Last Post primordialsoup77  
Started by arcolombo698, 12-03-2013, 01:46 PM
0 responses
1,226 views
0 reactions
Last Post arcolombo698  
No topics found.
  • Time
Clear All
No photos found.
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM
  • SEQadmin2
    How Immunogenomics Decodes Immunity’s Genetic Blueprint
    by SEQadmin2




    The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.

    This convergence of genetics, immunology, and computation...
    09-01-2026, 05:41 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Working...